243 related articles for article (PubMed ID: 18467677)
1. Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acid.
Rosen MB; Abbott BD; Wolf DC; Corton JC; Wood CR; Schmid JE; Das KP; Zehr RD; Blair ET; Lau C
Toxicol Pathol; 2008 Jun; 36(4):592-607. PubMed ID: 18467677
[TBL] [Abstract][Full Text] [Related]
2. Comparative hepatic effects of perfluorooctanoic acid and WY 14,643 in PPAR-alpha knockout and wild-type mice.
Wolf DC; Moore T; Abbott BD; Rosen MB; Das KP; Zehr RD; Lindstrom AB; Strynar MJ; Lau C
Toxicol Pathol; 2008 Jun; 36(4):632-9. PubMed ID: 18467680
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses.
Rosen MB; Thibodeaux JR; Wood CR; Zehr RD; Schmid JE; Lau C
Toxicology; 2007 Sep; 239(1-2):15-33. PubMed ID: 17681415
[TBL] [Abstract][Full Text] [Related]
4. Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR.
Rosen MB; Lee JS; Ren H; Vallanat B; Liu J; Waalkes MP; Abbott BD; Lau C; Corton JC
Toxicol Sci; 2008 May; 103(1):46-56. PubMed ID: 18281256
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA).
Guruge KS; Yeung LW; Yamanaka N; Miyazaki S; Lam PK; Giesy JP; Jones PD; Yamashita N
Toxicol Sci; 2006 Jan; 89(1):93-107. PubMed ID: 16221955
[TBL] [Abstract][Full Text] [Related]
6. Toxicogenomic analysis of the hepatic effects of perfluorooctanoic acid on rare minnows (Gobiocypris rarus).
Wei Y; Liu Y; Wang J; Tao Y; Dai J
Toxicol Appl Pharmacol; 2008 Feb; 226(3):285-97. PubMed ID: 17976672
[TBL] [Abstract][Full Text] [Related]
7. Perfluorooctanoic acid induced-developmental cardiotoxicity: are peroxisome proliferator activated receptor α (PPARα) and bone morphorgenic protein 2 (BMP2) pathways involved?
Jiang Q; Lust RM; DeWitt JC
J Toxicol Environ Health A; 2013; 76(11):635-50. PubMed ID: 23941634
[TBL] [Abstract][Full Text] [Related]
8. Urea cycle gene expression is suppressed by PFOA treatment in rats.
Walters MW; Wallace KB
Toxicol Lett; 2010 Aug; 197(1):46-50. PubMed ID: 20452409
[TBL] [Abstract][Full Text] [Related]
9. A species difference in the peroxisome proliferator-activated receptor α-dependent response to the developmental effects of perfluorooctanoic acid.
Albrecht PP; Torsell NE; Krishnan P; Ehresman DJ; Frame SR; Chang SC; Butenhoff JL; Kennedy GL; Gonzalez FJ; Peters JM
Toxicol Sci; 2013 Feb; 131(2):568-82. PubMed ID: 23143925
[TBL] [Abstract][Full Text] [Related]
10. Transactivation potencies of the Baikal seal (Pusa sibirica) peroxisome proliferator-activated receptor α by perfluoroalkyl carboxylates and sulfonates: estimation of PFOA induction equivalency factors.
Ishibashi H; Kim EY; Iwata H
Environ Sci Technol; 2011 Apr; 45(7):3123-30. PubMed ID: 21381677
[TBL] [Abstract][Full Text] [Related]
11. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
[TBL] [Abstract][Full Text] [Related]
12. Activation of sterol regulatory element-binding proteins in mice exposed to perfluorooctanoic acid for 28 days.
Yan S; Wang J; Dai J
Arch Toxicol; 2015 Sep; 89(9):1569-78. PubMed ID: 25092180
[TBL] [Abstract][Full Text] [Related]
13. Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARα and T- and B-cell targeting.
DeWitt JC; Williams WC; Creech NJ; Luebke RW
J Immunotoxicol; 2016; 13(1):38-45. PubMed ID: 25594567
[TBL] [Abstract][Full Text] [Related]
14. Expression of a novel cytochrome P450 4T gene in rare minnow (Gobiocypris rarus) following perfluorooctanoic acid exposure.
Liu Y; Wang J; Liu Y; Zhang H; Xu M; Dai J
Comp Biochem Physiol C Toxicol Pharmacol; 2009 Jul; 150(1):57-64. PubMed ID: 19258050
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitous environmental pollutant perfluorooctanoicacid inhibits feeding behavior via peroxisome proliferator-activated receptor-alpha.
Asakawa A; Toyoshima M; Harada KH; Fujimiya M; Inoue K; Koizumi A
Int J Mol Med; 2008 Apr; 21(4):439-45. PubMed ID: 18360689
[TBL] [Abstract][Full Text] [Related]
16. The identification of apolipoprotein genes in rare minnow (Gobiocypris rarus) and their expression following perfluorooctanoic acid exposure.
Fang X; Wei Y; Liu Y; Wang J; Dai J
Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):152-9. PubMed ID: 19800026
[TBL] [Abstract][Full Text] [Related]
17. PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.
Rosen MB; Das KP; Rooney J; Abbott B; Lau C; Corton JC
Toxicology; 2017 Jul; 387():95-107. PubMed ID: 28558994
[TBL] [Abstract][Full Text] [Related]
18. Hepatic carboxylesterases are differentially regulated in PPARα-null mice treated with perfluorooctanoic acid.
Wen X; Baker AA; Klaassen CD; Corton JC; Richardson JR; Aleksunes LM
Toxicology; 2019 Mar; 416():15-22. PubMed ID: 30685356
[TBL] [Abstract][Full Text] [Related]
19. Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.
Schlezinger JJ; Puckett H; Oliver J; Nielsen G; Heiger-Bernays W; Webster TF
Toxicol Appl Pharmacol; 2020 Oct; 405():115204. PubMed ID: 32822737
[TBL] [Abstract][Full Text] [Related]
20. Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths.
Wolf CJ; Takacs ML; Schmid JE; Lau C; Abbott BD
Toxicol Sci; 2008 Nov; 106(1):162-71. PubMed ID: 18713766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
